Bracco D, Favre J B, Ravussin P
Département d'anesthésiologie et de réanimation, hôpital de Sion, 1950 Sion, Suisse.
Ann Fr Anesth Reanim. 2001 Feb;20(2):203-12. doi: 10.1016/s0750-7658(00)00286-0.
Hyponatraemia is a frequent complication in neurologically injured patients; it is a secondary cerebral injury. Hyponatraemia leads to consciousness problems, convulsions, worsening of the neurological status and thus the neurological evaluation. Hyponatraemia is secondary to free water retention (inappropriate ADH secretion) or to renal salt loss. The cerebral salt wasting syndrome (CSWS) has been described with head injury, subarachnoid haemorrhage and after several sorts of brain insults. It is characterised by an increased natriuresis and diuresis. Diagnosis is based on hyponatraemia, hypernatriuresis, increased diuresis and hypovolaemia. However, inappropriate ADH secretion and CSWS share several diagnostic criteria. The atrial natriuretic factor and the C-type natriuretic factors play a role in the development of the CSWS. The diagnostic approach and monitoring are based on the assessment of sodium and water losses. Therapy is based on correction of the circulating volume and natraemia. Speed of correction is a matter of debate: slow correction presents the risk of further neurological injury whereas rapid correction presents the risk of central pontine myelinosis.
低钠血症是神经损伤患者常见的并发症,是一种继发性脑损伤。低钠血症会导致意识问题、惊厥、神经状态恶化,进而影响神经功能评估。低钠血症继发于自由水潴留(抗利尿激素分泌不当)或肾性失盐。脑性盐耗综合征(CSWS)已在颅脑损伤、蛛网膜下腔出血及多种脑损伤后被描述。其特征为尿钠排泄增加和利尿增多。诊断依据为低钠血症、高钠尿症、利尿增多和血容量减少。然而,抗利尿激素分泌不当和CSWS有若干共同的诊断标准。心房利钠因子和C型利钠因子在CSWS的发生发展中起作用。诊断方法和监测基于对钠和水丢失的评估。治疗基于循环血容量和血钠浓度的纠正。纠正速度存在争议:缓慢纠正有进一步神经损伤的风险,而快速纠正有发生中枢性 pontine 髓鞘溶解症的风险。